Lucknow, March 6 (IANS) As many as 129 (or 76 per cent) out of 169 endemic blocks are now gearing up for the pre-transmission survey (pre-TAS), in eliminating lymphatic filariasis in Uttar Pradesh.
Lymphatic filariasis is a neglected tropical disease caused by the common household mosquito.
Symptoms of this 100 per cent preventable disease and incurable disease may take up to 15 years to show up but they eventually cause lifelong disability and morbidity.
According to data from the Union ministry of health and family welfare, Rajiv Manjhi, joint secretary, Union Ministry of Health and Family Welfare, said: “India accounts for over 90 per cent of the world’s LF burden and the nation has pledged to eliminate the disease by the end of 2027, which is three years ahead of the global deadline of 2030. However, we are quite close towards our goal and if we can maintain our dominance over the disease, the target may be achieved before time.”
As per defined standards, elimination of LF means that the disease ceases to be a public health problem.
This will happen when the microfilaria infection rate is brought down to less than 1 per cent in all the endemic districts.
“The first level of the assessment to ascertain whether LF has been eliminated in a place or not begins with night blood survey in which blood samples from the endemic population are taken and tested for the disease-causing microbe. If the score on this count is less than 0.1 per cent, the endemic region gears up for what is called the pre-TAS and 129 out of 169 blocks of UP are at this stage,” he explained.
Once the pre-TAS is cleared, TAS is conducted to determine that the infection has been reduced below the threshold and preventive drug administration may be withheld.
Thereafter, second and third rounds of TAS follow to ensure that the prevalence does not go above the threshold level. Two preventive medicine regimen based scientific studies of endemic block are rolled out.
While in mass drug administration (MDA) category, DEC and Albendazole are prescribed, Ivermectin is included in the Triple Drug Therapy (TDT).
–IANS
amita/prw
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
